Abstract

The disrupted-in-schizophrenia 1 (DISC1) gene was identified as a genetic risk factor for chronic mental illnesses (CMI) such as schizophrenia, bipolar disorder and severe recurrent depression. Insoluble aggregated DISC1 variants were found in the cingular cortex of sporadic, i.e. non-genetic, CMI patients. This suggests protein pathology as a novel, additional pathogenic mechanism, further corroborated in a recent transgenic rat model presenting DISC1 aggregates. Since the potential role of aggregation of DISC1 in sporadic CMI is unknown, we investigated whether DISC1 undergoes aggregation in cell culture and could spread between neuronal cells in a prion-like manner, as shown for amyloid proteins in neurodegenerative diseases. Co-culture experiments between donor cells forming DISC1 aggregates and acceptor cells showed that 4.5% of acceptor cells contained donor-derived DISC1 aggregates, thus indicating an efficient transfer in vitro. DISC1 aggregates were found inside tunnelling nanotubes (TNTs) and transfer was enhanced by increasing TNT formation and notably by dopamine treatment, which also induces DISC1 aggregation. These data indicate that DISC1 aggregates can propagate between cells similarly to prions, thus providing some molecular basis for the role of protein pathology in CMI.

Highlights

  • Schizophrenia is a purely clinical diagnosis for a chronic brain disorder that is characterized clinically by positive symptoms such as delusions, thought disorders and hallucinations, as well as negative symptoms such as flattened affect or lack of drive, and cognitive symptoms such as working memory deficits

  • In line with previous reports, we found that GFP-disrupted-inschizophrenia 1 (DISC1) formed aggregates in CAD cells at all time points

  • Quantification of the number of DISC1 aggregates revealed that while the amount of DISC1 aggregates was similar at 12 h and 24 h post-transfection, the number significantly decreased at 36 h after transfection

Read more

Summary

Introduction

Schizophrenia is a purely clinical diagnosis for a chronic brain disorder that is characterized clinically by positive symptoms such as delusions, thought disorders and hallucinations, as well as negative symptoms such as flattened affect or lack of drive, and cognitive symptoms such as working memory deficits. Anatomical abnormalities such as enlarged ventricles and cellular abnormalities in cortical layering of inter-neurons have been reported in schizophrenia [1], but the pathogenesis of this disease is largely unknown. DISC1 protein is involved in neurite outgrowth and cortical development [9,10,11], and a wealth of evidence has corroborated DISC1 as a gene related to behavioural control [3]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call